Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
- USD | -.--% | +0,14% | -0,05% |
2019 | Transcript : Novartis AG, The Medicines Company - M&A Call | |
2019 | Transcript : The Medicines Company - Special Call |
Omzet 2017 | 44,79 mln. 41,28 mln. | Omzet 2018 | 6,14 mln. 5,66 mln. | Marktkapitalisatie | 1,41 mld. 1,3 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2017 | -708 mln. -653 mln. | Nettowinst (verlies) 2018 | -123 mln. -113 mln. | EV/omzet 2017 | 55,1 x |
Nettoschuld 2017 | 498 mln. 459 mln. | Nettoschuld 2018 | 552 mln. 509 mln. | EV/omzet 2018 | 319 x |
K/w-verhouding 2017 |
-2,79
x | K/w-verhouding 2018 |
-11,4
x | Werknemers | - |
Dividendrendement 2017 * |
-
| Dividendrendement 2018 |
-
| Vrij verhandelbaar | 92,97% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Krishna Gorti
IRC | Investor Relations Contact | - | - |
Stephen M. Rodin
LAW | General Counsel | 47 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
John C. Kelly
BRD | Director/Board Member | 81 | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-0,05% | 6,79 mld. | |
+15,91% | 41,97 mld. | |
+22,40% | 22,34 mld. | |
+18,48% | 15,25 mld. | |
+16,12% | 14 mld. | |
+45,12% | 12,06 mld. | |
-9,58% | 6,8 mld. | |
-8,87% | 5,73 mld. | |
+14,18% | 5,49 mld. | |
+4,00% | 4,62 mld. |